Norges Bank Halozyme Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$37.81 - $52.4 $46 Million - $63.7 Million
1,216,161 New
1,216,161 $63.7 Million
Q4 2023

Feb 09, 2024
BUY
$33.32 - $42.1 $40.5 Million - $51.2 Million
1,215,769 New
1,215,769 $44.9 Million
Q3 2023

Nov 13, 2024
BUY
$36.46 - $44.03 $46.2 Million - $55.8 Million
1,268,350 New
1,268,350 $48.5 Million
Q3 2023

Nov 13, 2023
SELL
$36.46 - $44.03 $36.1 Million - $43.5 Million
-988,989 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$30.28 - $38.74 $1.36 Million - $1.74 Million
44,819 Added 3.69%
1,260,980 $45.5 Million
Q2 2023

Aug 14, 2023
SELL
$30.28 - $38.74 $37.4 Million - $47.8 Million
-1,233,731 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$32.86 - $55.7 $35.8 Million - $60.7 Million
1,089,600 New
1,089,600 $41.6 Million
Q4 2022

Feb 14, 2023
BUY
$40.06 - $59.44 $38 Million - $56.4 Million
948,271 New
948,271 $54 Million
Q3 2022

Nov 13, 2023
BUY
$38.53 - $51.78 $38.1 Million - $51.2 Million
988,989 New
988,989 $39.1 Million
Q2 2022

Aug 14, 2023
BUY
$37.35 - $48.3 $46.1 Million - $59.6 Million
1,233,731 New
1,233,731 $54.3 Million
Q1 2022

May 12, 2023
BUY
$31.97 - $41.06 $7.59 Million - $9.75 Million
237,394 Added 25.03%
1,185,665 $47.3 Million
Q1 2022

May 09, 2022
SELL
$31.97 - $41.06 $33.4 Million - $43 Million
-1,046,198 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$31.82 - $40.75 $33.3 Million - $42.6 Million
1,046,198 New
1,046,198 $42.1 Million
Q3 2021

Nov 14, 2022
BUY
$38.47 - $46.42 $39.4 Million - $47.6 Million
1,024,681 New
1,024,681 $41.7 Million
Q3 2021

Nov 05, 2021
SELL
$38.47 - $46.42 $31.1 Million - $37.5 Million
-807,540 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$38.84 - $51.31 $31.4 Million - $41.4 Million
807,540 New
807,540 $36.7 Million
Q2 2021

Aug 10, 2021
SELL
$38.84 - $51.31 $46.6 Million - $61.5 Million
-1,199,438 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$39.51 - $51.45 $47.4 Million - $61.7 Million
1,199,438 New
1,199,438 $50 Million
Q1 2021

May 07, 2021
SELL
$39.51 - $51.45 $44.9 Million - $58.5 Million
-1,136,645 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$25.81 - $43.62 $29.3 Million - $49.6 Million
1,136,645 New
1,136,645 $48.5 Million
Q4 2020

Feb 10, 2021
SELL
$25.81 - $43.62 $27 Million - $45.7 Million
-1,047,150 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$25.74 - $29.63 $27 Million - $31 Million
1,047,150 New
1,047,150 $27.5 Million
Q3 2020

Nov 10, 2020
SELL
$25.74 - $29.63 $31.1 Million - $35.8 Million
-1,208,474 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$16.25 - $26.81 $19.6 Million - $32.4 Million
1,208,474 New
1,208,474 $32.4 Million
Q2 2020

Aug 07, 2020
SELL
$16.25 - $26.81 $24.8 Million - $41 Million
-1,528,524 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$13.9 - $21.83 $21.2 Million - $33.4 Million
1,528,524 New
1,528,524 $27.5 Million
Q1 2020

May 08, 2020
SELL
$13.9 - $21.83 $23.7 Million - $37.3 Million
-1,708,271 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$14.93 - $19.53 $25.5 Million - $33.4 Million
1,708,271 New
1,708,271 $30.3 Million
Q4 2019

Feb 12, 2020
SELL
$14.93 - $19.53 $27 Million - $35.4 Million
-1,810,203 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$15.2 - $17.69 $27.5 Million - $32 Million
1,810,203 New
1,810,203 $28.1 Million
Q3 2019

Nov 08, 2019
SELL
$15.2 - $17.69 $24.9 Million - $28.9 Million
-1,635,203 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$14.75 - $17.26 $24.1 Million - $28.2 Million
1,635,203 New
1,635,203 $28.1 Million
Q2 2019

Aug 09, 2019
SELL
$14.75 - $17.26 $23.9 Million - $27.9 Million
-1,618,760 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$13.33 - $18.66 $21.6 Million - $30.2 Million
1,618,760 New
1,618,760 $23.7 Million
Q4 2018

Feb 08, 2019
SELL
$13.33 - $18.66 $21.6 Million - $30.2 Million
-1,618,760 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$16.68 - $18.41 $27 Million - $29.8 Million
1,618,760 New
1,618,760 $29.4 Million
Q3 2018

Nov 09, 2018
SELL
$16.68 - $18.41 $27 Million - $29.8 Million
-1,618,760 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$16.87 - $20.3 $27.3 Million - $32.9 Million
1,618,760 New
1,618,760 $27.3 Million
Q2 2018

Jul 23, 2018
SELL
$16.87 - $20.3 $17.6 Million - $21.2 Million
-1,045,610 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$17.06 - $21.2 $17.8 Million - $22.2 Million
1,045,610 New
1,045,610 $20.5 Million
Q1 2018

May 09, 2018
SELL
$17.06 - $21.2 $17 Million - $21.1 Million
-995,008 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$16.75 - $20.8 $16.7 Million - $20.7 Million
995,008 New
995,008 $20.2 Million
Q4 2017

Feb 09, 2018
SELL
$16.75 - $20.8 $16.7 Million - $20.7 Million
-995,008 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$11.76 - $17.4 $11.7 Million - $17.3 Million
995,008 New
995,008 $17.3 Million
Q3 2017

Nov 07, 2017
SELL
$11.76 - $17.4 $11.7 Million - $17.3 Million
-995,008 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-19,844 Reduced 1.96%
995,008 $12.8 Million
Q3 2016

Nov 13, 2017
BUY
N/A
1,014,852
1,014,852 $0

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email